Ugur Onsel Turk

Dr. Ugur Onsel Turk

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2015 in Cardiology Journal
Verified
Journal Article
Open access
UTUgur Onsel Turk
Ugur Onsel Turk
ETEsref Tuncer
Esref Tuncer
EAEmin Alioglu
Emin Alioglu
KYKivanc Yuksel
Kivanc Yuksel
NPNihat Pekel
Nihat Pekel
ITIstemihan Tengiz
Istemihan Tengiz
Warfarin is highly efficacious in reducing stroke risk in patients with atrial fibrillation (AF). However, its safety and efficacy in stroke prevention is markedly influenced by its time in therapeutic range (TTR). The quality of anticoagulant therapy varies considerably among countries. Representative data concerning the quality of anticoagulant therapy and its effects on clinical outcomes in Turkey are lacking. Warfarin in Therapeutic Range (WATER) registry is a prospective, observational study which followed 572 AF patients (mean age 67.3 ± 12 years; females 60%; 71% non-valvular AF) treated with warfarin. At a median of 22-month follow-up, the mean TTR value was 42.3 ± 18% (median: 40%) for the whole population and lower in non-valvular AF su group than valvular AF subgroup (40.3 ± 18 vs. 46.9 ± 19, respectively, p < 0.001). Death, cardiac hospital-ization and minor bleeding rates were higher in the group with TTR value < 40% than the group with > 40% (3.4% vs. 5.9%; 28.6% vs. 35.4%; 36.5% vs. 41.7%, respectively, all of them p < 0.001). A correlation analysis showed a negative correlation between age and TTR value (r = -0.178, p < 0.001). Mean CHA2DS2VASc score was 3.63 ± 1.5 and mean HASBLED score was 2.38 ± 1.01 in the non-valvular AF group. A negative correlation was observed between TTR levels and CHA2DS2VASc score. WATER provides insight into the anticoagulation control status of AF patients in Turkey. The quality of anticoagulation was poor. Strategies should be undertaken by clinicians and patients to improve TTR. New oral anticoagulant agents may be perfect alternatives for non-valvular AF patients.

1 January 2009 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
EAEmin Alioglu
Emin Alioglu
NTNurullah Tuzun
Nurullah Tuzun
FSFahri Sahin
Fahri Sahin
BKBuket Kosova
Buket Kosova
SSSerkan Saygi
Serkan Saygi
EEErtugrul Ercan
Ertugrul Ercan
A 68-year-old woman presented with acute chest pain and a greatly increased platelet count. Cardiac catheterization revealed subtotal occlusion and a thrombus-like filling defect in the right coronary artery. The patient was successfully treated with intravenous tirofiban. Essential thrombocythemia was diagnosed based on bone marrow findings, clinical presentation and laboratory analysis. The relationship between intracoronary thrombus and essential thrombocythemia is discussed.

10 April 2006 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ITIstemihan Tengiz
Istemihan Tengiz
EEErtugrul Ercan
Ertugrul Ercan
EAEmin Alioglu
Emin Alioglu
UTUgur Onsel Turk
Ugur Onsel Turk
Background: Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal chamber of the ventriculum on the hemodynamic assessment. Case presentation: The present case represents successful percutaneous treatment with septal ablation to patient with MVOHC associated with systolic anterior motion of the mitral valve and obstruction at both the mid-ventricular and outflow levels. Conclusion: Alcohol septal ablation has been proposed as less invasive alternatives to surgery in patients with MVOHC.

1 February 2010 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
UTUgur Onsel Turk
Ugur Onsel Turk
EAEmin Alioglu
Emin Alioglu
BKBahadir Kirilmaz
Bahadir Kirilmaz
HDHamza Duygu
Hamza Duygu
NTNurullah Tuzun
Nurullah Tuzun
EEErtugrul Ercan
Ertugrul Ercan

1 March 2013
Verified
Open access
ETEsref Tuncer
Esref Tuncer
UTUgur Onsel Turk
Ugur Onsel Turk
EAEmin Alioglu
Emin Alioglu
Coronary aneurysms represent anomalies identified in 0.15%-4.9% of patients undergoing coronary angiography. At present, there is no uniform definition of this pathology. Aneurysms of the left main coronary artery (LMCA) are extremely uncommon, with an incidence of 0.1%. It has been demonstrated that atherosclerosis is the main cause of these anomalies in adults, and Kawasaki disease in children and adolescents. Other causes include connective tissue disorders, trauma, vasculitis, congenital, mycotic, and idiopathic. These dilated sections of the coronary artery are not benign pathology because they are subject to spasm, thrombosis, and subsequent distal embolism, spontaneous dissection and rupture. Treatment options include anticoagulation, custom-made covered stents, reconstruction, resection, and exclusion with bypass. Our report on an old case illustrates the giant saccular LMCA aneurysm leading to myocardial ischemia due to coronary steal phenomenon.

1 February 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
EAEmin Alioglu
Emin Alioglu
EEErtugrul Ercan
Ertugrul Ercan
GTGulden Sonmez Tamer
Gulden Sonmez Tamer
CDCan Duman
Can Duman
UTUgur Turk
Ugur Turk
SSSerkan Saygi
Serkan Saygi